Key facts
- It has raised $840K; the latest was Early Stage VC ($840K) in Jul 2025.
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Petgenoma (Laboratory Services (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Petgenoma (Laboratory Services (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Petgenoma (Laboratory Services (Healthcare))
Provider of genetic testing services intended to detect diseases and genetic traits in dogs. The company offers DNA-based diagnostics, including ancestry profiling, health risk screening, trait prediction, and customized wellness insights, enabling pet owners, breeders, and veterinary professionals to make informed care decisions, prevent health issues, and support long-term well-being through a deeper understanding of genetics.
- Sector
- Healthcare
- HQ
- Sao Paulo, Brazil
- Founded
- 2023
- Employees
- 13
- Website
- petgenoma.com.br/
- Ownership
- Privately Held (backing)
Petgenoma (Laboratory Services (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Petgenoma (Laboratory Services (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Petgenoma (Laboratory Services (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.